All In MedTech

Device Trial Radar · NCT02061696

ARISTOCRAT-A Randomized Controlled Trial Evaluating Closure Following Access With the AXERA (Device Name) 2 Access System

A Randomized Controlled Trial to Assess Safety and Efficacy of AXERA 2 Access System Compared to Manual Compression

Last checked: Nov 20, 2026Latest source record: May 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

39

Actual

Start

Jan 2014

Primary completion

Dec 2015

Study completion Jan 2016

Sponsor

Lead sponsor
Frank SaltielAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Borgess Medical Center; Borgess Cardiology Group; Borgess Heart Center for Excellence
First posted
Feb 13, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of the research study is to observe the clinical safety, effectiveness and patient satisfaction of the AXERA 2 Access System in subjects undergoing coronary angiographic and possible Percutaneous Coronary Intervention (PCI) through the femoral artery when compared to standard manual compression.

Conditions

  • Coronary Artery Disease

Interventions

  • Vascular Access DeviceDevice

    AXERA 2 Access System with Reduced Manual Compression

  • Standard Manual CompressionProcedure

    Closure procedure by Manual Compression

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Any Site-Related Major Adverse EventsTime frame: Up to 37 days post procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Borgess Medical Center

    Kalamazoo, Michigan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.